The in vitro effect of ridogrel on platelet function in normocholesterolaemic and familial hypercholesterolaemic type IIa subjects

Thrombosis Research
N H Naran, N Chetty

Abstract

Platelets from familial hypercholesterolaemia type IIa patients are hyperreactive and produce increased amounts of thromboxane A2. These modifications of platelet function may play an important role in the occurrence of premature atherosclerosis. One approach to the prevention of the thromboembolic complications of atherosclerosis is the use of antiplatelet agents which depress platelet function. Ridogrel, a combined thromboxane synthase inhibitor and thromboxane A2/prostaglandin endoperoxide receptor blocker inhibits platelet aggregation. This study was designed to investigate the in vitro effect of ridogrel on platelet function in normocholesterolaemic and familial hypercholesterolaemia type IIa subjects. In citrated platelet rich plasma ridogrel significantly inhibited platelet aggregation and thromboxane A2 production in response to collagen, ADP and arachidonic acid stimulation. In washed platelets ridogrel significantly decreased aggregation and serotonin release. Ridogrel significantly increased cAMP levels in response to thrombin stimulation. In conclusion, ridogrel at low concentrations significantly inhibited the in vitro function of platelets in a dose dependant manner in both normocholesterolaemic subjects and famil...Continue Reading

References

Jan 1, 1979·Lancet·E TremoliC Galli
Dec 1, 1975·Thrombosis Research·K K WuM B Megan
Sep 1, 1976·Proceedings of the Society for Experimental Biology and Medicine·J P CazenaveJ F Mustard
Mar 1, 1975·The Journal of Clinical Investigation·S J ShattilR A Cooper
Jan 1, 1992·Human Mutation·H H HobbsJ L Goldstein
Dec 31, 1992·Clinica Chimica Acta; International Journal of Clinical Chemistry·N Chetty, N H Naran
Jun 1, 1990·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·H SuzukiH Yamazaki
Sep 1, 1989·The Journal of Clinical Investigation·E LeitersdorfH H Hobbs
Jun 1, 1989·Journal of Cellular Physiology·M H KrollA I Schafer
Apr 1, 1971·Proceedings of the Society for Experimental Biology and Medicine·N G ArdlieJ F Mustard
Feb 21, 1974·The New England Journal of Medicine·A C CarvalhoR S Lees
Jul 1, 1967·Circulation·J JensenV Kornerup
Aug 1, 1983·Atherosclerosis·A YamamotoT Kikkawa
Nov 27, 1981·JAMA : the Journal of the American Medical Association·S Wessler
May 1, 1961·Archives of Biochemistry and Biophysics·J MOLNAR, L LORAND
May 1, 1964·The Journal of Clinical Investigation·R H ASTER, J H JANDL

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.